Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

SELL
$0.14 - $0.21 $6,974 - $10,461
-49,817 Reduced 49.49%
50,850 $7,000
Q3 2022

Nov 10, 2022

BUY
$0.14 - $1.83 $9,500 - $124,187
67,862 Added 206.86%
100,667 $14,000
Q2 2022

Aug 10, 2022

BUY
$1.34 - $2.08 $4,103 - $6,368
3,062 Added 10.29%
32,805 $53,000
Q1 2022

May 16, 2022

BUY
$1.1 - $2.17 $470 - $928
428 Added 1.46%
29,743 $45,000
Q4 2021

Feb 14, 2022

SELL
$1.99 - $3.1 $7,770 - $12,105
-3,905 Reduced 11.75%
29,315 $58,000
Q3 2021

Nov 15, 2021

BUY
$2.47 - $3.34 $9,645 - $13,042
3,905 Added 13.32%
33,220 $104,000
Q2 2021

Aug 13, 2021

SELL
$2.56 - $3.35 $8,537 - $11,172
-3,335 Reduced 10.21%
29,315 $89,000
Q1 2021

May 12, 2021

SELL
$2.01 - $5.05 $42,276 - $106,216
-21,033 Reduced 39.18%
32,650 $106,000
Q4 2020

Feb 11, 2021

BUY
$1.89 - $2.55 $45,290 - $61,105
23,963 Added 80.63%
53,683 $112,000
Q3 2020

Nov 12, 2020

BUY
$2.46 - $6.15 $30,577 - $76,444
12,430 Added 71.89%
29,720 $74,000
Q2 2020

Jul 31, 2020

BUY
$2.01 - $5.95 $2,506 - $7,419
1,247 Added 7.77%
17,290 $102,000
Q1 2020

May 01, 2020

BUY
$1.87 - $4.47 $2,891 - $6,910
1,546 Added 10.66%
16,043 $39,000
Q4 2019

Feb 14, 2020

BUY
$2.48 - $8.1 $8,942 - $29,208
3,606 Added 33.11%
14,497 $55,000
Q3 2019

Nov 14, 2019

SELL
$8.22 - $11.2 $19,095 - $26,017
-2,323 Reduced 17.58%
10,891 $91,000
Q2 2019

Aug 14, 2019

BUY
$10.05 - $14.25 $10,713 - $15,190
1,066 Added 8.78%
13,214 $149,000
Q1 2019

May 14, 2019

BUY
$11.82 - $14.48 $14,751 - $18,071
1,248 Added 11.45%
12,148 $155,000
Q4 2018

Feb 14, 2019

SELL
$10.8 - $17.94 $68,547 - $113,865
-6,347 Reduced 36.8%
10,900 $138,000
Q3 2018

Nov 14, 2018

BUY
$10.92 - $18.18 $129,161 - $215,033
11,828 Added 218.27%
17,247 $311,000
Q2 2018

Aug 14, 2018

BUY
$10.0 - $17.87 $51,490 - $92,012
5,149 Added 1907.04%
5,419 $82,000
Q1 2018

May 15, 2018

BUY
$9.36 - $15.22 $2,527 - $4,109
270 New
270 $4,000

Others Institutions Holding OBSV

About ObsEva SA


  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.